Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Benha University
Recurrent pediatric glaucoma following Ahmed Glaucoma Valve (AGV) implantation presents a therapeutic challenge. This study evaluates the efficacy and safety of combining subconjunctival bevacizumab with mitomycin C (MMC) during AGV revision surgery in pediatric patients with recurrent glaucoma.
Age
0–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
children under 12 years with previous AGV implantation for primary congenital glaucoma
You may not be if
age \>12 years, eyes with no light perception, and those with prior cyclodestructive procedures.
